Started a position in AROW this morning. 3.3% yield, 42% payout ratio, 5yr DGR of 3.7%, 28 years of dividend growth. Its 10-year average P/E is 14.5, which would translate to a share price of $37.62 if it reverts to its average (which would represent a 20% upside from current price).
(02-09-2021, 10:41 AM)Otter Wrote: [ -> ]Started a position in AROW this morning. 3.3% yield, 42% payout ratio, 5yr DGR of 3.7%, 28 years of dividend growth. Its 10-year average P/E is 14.5, which would translate to a share price of $37.62 if it reverts to its average (which would represent a 20% upside from current price).
Added to my Watch List.
Wow, JNJ is my top performer so far today. It's been a while since he's been top of the heap.
Added BP. It's slowly creeping into my top 15 lol
(02-09-2021, 11:04 AM)divmenow Wrote: [ -> ] (02-09-2021, 10:56 AM)fenders53 Wrote: [ -> ] (02-09-2021, 10:40 AM)divmenow Wrote: [ -> ] (02-09-2021, 10:37 AM)fenders53 Wrote: [ -> ] (02-09-2021, 10:19 AM)ken-do-nim Wrote: [ -> ]Got a little ZOM just because everyone is talking about it
Reduced my position in CURE and started a new position in TQQQ.
Dump all your smelly dividend stocks fast. Everyone here is putting a second mortage on their home and buying ZOM tomorrow. Spread the word around the internet. Â
I think your on to something hereÂ
I added more ZOM at $2.14Â
If this works, a lunch date with the SEC maybe?Â
On a more serious note, some DD on ZOM. They are trying to bring VET equipment to market. They sell nothing to my knowledge presently.  They neither manufacture the equipment nor sell it directly. There is chatter on the net that their may be a patent dispute between manufacturers. With the dilution and SP runup, ZOM is about a 2B market cap now I believe. They say $2B is the TAM for the test equipment. Not a fake company, nor is it worth $50. Just trying to keep it real.
From the CEO of ZOM
We are, of course, approaching our planned March 30th commercial launch of TRUFORMA™, our point-of-care diagnostic platform. Commercialization plans remain on track and we are beginning to build inventory. As our sales effort begins, we intend to implement a controlled release phase wherein we slowly begin the sale of the TRUFORMA instrument and at least three assays in a limited geographic area in order to test our distribution system to be sure that it performs as we anticipate in these COVID-challenged times. We then expect to add two more assays later in 2021 as we continue to pursue a limited target market. The lessons learned during this COVID-impacted period are expected to be invaluable as we proceed into the future.  Toward the end of 2021, we hope to expand our geographic coverage if market conditions justify such an expansion.
Sounds like good news to meÂ
I read every bit of their website some time ago when my friend was asking me to screen for fake companies. It does sound like a product that will sell. What's that make ZOM stock worth? Hell who even knows? None of this news is that fresh. The Momo gang is playing. Short interest isn't extremely high yet.
(02-09-2021, 11:10 AM)fenders53 Wrote: [ -> ] (02-09-2021, 11:04 AM)divmenow Wrote: [ -> ] (02-09-2021, 10:56 AM)fenders53 Wrote: [ -> ] (02-09-2021, 10:40 AM)divmenow Wrote: [ -> ] (02-09-2021, 10:37 AM)fenders53 Wrote: [ -> ]Dump all your smelly dividend stocks fast. Everyone here is putting a second mortage on their home and buying ZOM tomorrow. Spread the word around the internet. Â
I think your on to something hereÂ
I added more ZOM at $2.14Â
If this works, a lunch date with the SEC maybe?Â
On a more serious note, some DD on ZOM. They are trying to bring VET equipment to market. They sell nothing to my knowledge presently.  They neither manufacture the equipment nor sell it directly. There is chatter on the net that their may be a patent dispute between manufacturers. With the dilution and SP runup, ZOM is about a 2B market cap now I believe. They say $2B is the TAM for the test equipment. Not a fake company, nor is it worth $50. Just trying to keep it real.
From the CEO of ZOM
We are, of course, approaching our planned March 30th commercial launch of TRUFORMA™, our point-of-care diagnostic platform. Commercialization plans remain on track and we are beginning to build inventory. As our sales effort begins, we intend to implement a controlled release phase wherein we slowly begin the sale of the TRUFORMA instrument and at least three assays in a limited geographic area in order to test our distribution system to be sure that it performs as we anticipate in these COVID-challenged times. We then expect to add two more assays later in 2021 as we continue to pursue a limited target market. The lessons learned during this COVID-impacted period are expected to be invaluable as we proceed into the future.  Toward the end of 2021, we hope to expand our geographic coverage if market conditions justify such an expansion.
Sounds like good news to meÂ
I read every bit of their website some time ago when my friend was asking me to screen for fake companies. It does sound like a product that will sell. What's that make ZOM stock worth? Hell who even knows? None of this news is that fresh. The Momo gang is playing. Short interest isn't extremely high yet.
I say $8-10 this year then $20 in 2022. We are getting on the ground floor nowÂ
Fenders is just beside himself for not buying in under $1Â
Â
Don't worry you will be paying $4 next week to get in lol
And Divmenow. You are a wiz. I just double my money in HRVOFÂ and tripled it in OGI todayÂ
TLRY up $14 yesss!!Â
(02-09-2021, 11:18 AM)stockguru Wrote: [ -> ] (02-09-2021, 11:10 AM)fenders53 Wrote: [ -> ] (02-09-2021, 11:04 AM)divmenow Wrote: [ -> ] (02-09-2021, 10:56 AM)fenders53 Wrote: [ -> ] (02-09-2021, 10:40 AM)divmenow Wrote: [ -> ]I think your on to something hereÂ
I added more ZOM at $2.14Â
If this works, a lunch date with the SEC maybe?Â
On a more serious note, some DD on ZOM. They are trying to bring VET equipment to market. They sell nothing to my knowledge presently.  They neither manufacture the equipment nor sell it directly. There is chatter on the net that their may be a patent dispute between manufacturers. With the dilution and SP runup, ZOM is about a 2B market cap now I believe. They say $2B is the TAM for the test equipment. Not a fake company, nor is it worth $50. Just trying to keep it real.
From the CEO of ZOM
We are, of course, approaching our planned March 30th commercial launch of TRUFORMA™, our point-of-care diagnostic platform. Commercialization plans remain on track and we are beginning to build inventory. As our sales effort begins, we intend to implement a controlled release phase wherein we slowly begin the sale of the TRUFORMA instrument and at least three assays in a limited geographic area in order to test our distribution system to be sure that it performs as we anticipate in these COVID-challenged times. We then expect to add two more assays later in 2021 as we continue to pursue a limited target market. The lessons learned during this COVID-impacted period are expected to be invaluable as we proceed into the future.  Toward the end of 2021, we hope to expand our geographic coverage if market conditions justify such an expansion.
Sounds like good news to meÂ
I read every bit of their website some time ago when my friend was asking me to screen for fake companies. It does sound like a product that will sell. What's that make ZOM stock worth? Hell who even knows? None of this news is that fresh. The Momo gang is playing. Short interest isn't extremely high yet.
I say $8-10 this year then $20 in 2022. We are getting on the ground floor nowÂ
Fenders is just beside himself for not buying in under $1Â Â
Don't worry you will be paying $4 next week to get in lol
And Divmenow. You are a wiz. I just double my money in HRVOFÂ and tripled it in OGI todayÂ
TLRY up $14 yesss!!Â
LOL yes I am.  Pretty sure I researched this scam way before most of you. My buddy I helped start "Investing" is now up over 300% since fall. He thinks I am a guru so you guys can all go kick rocks lol.  The penny stock junk is just for fun. I did have a limit order in a time or two sub $1 and got distracted. I blame GME lol.
Since everyone wants to buy ZOM which is a $2 billion company with no products.
Why not jump into the pet healthcare thing with PETQ. Half the market cap and actual products to sell!
And I actually want to buy Callaway now because of TopGolf. But yeah I might have to wait a while and do some more research in both this and DS. I do love the idea of their entertainment venues.
(02-09-2021, 09:59 AM)Otter Wrote: [ -> ]Sold some 01/21/2022 $25 PLTR Puts for $6.00/contract. Effective entry price of $19.00/share if they get assigned. Good income in the meantime, and may buy them back if it continues to trend upwards.
Not bad for a 24% return if it runs up. I have been waiting for last 2 weeks to renew my pltr puts. I think I am going to sit out Feb 11 and mostly till end of Feb.
(02-09-2021, 11:35 AM)crimsonghost747 Wrote: [ -> ]Since everyone wants to buy ZOM which is a $2 billion company with no products.
Why not jump into the pet healthcare thing with PETQ. Half the market cap and actual products to sell!
And I actually want to buy Callaway now because of TopGolf. But yeah I might have to wait a while and do some more research in both this and DS. I do love the idea of their entertainment venues.
I really would like to hear more pet tickers. That's not going to stop being trendy. It's something average Joe investor actually has a bit of understanding and passion about. That matters. I would like to point out that pets.com is the poster child for tech bubble craziness 1999. Is this a sign? Â
Anyone getting in on the Bumble IPO? I just participated in in. Hope I'm approved lol
I normally don't participate in IPO's. But this one I like lol
The last IPO I took part in was SHAK